Treating Cardiac Edema
pulmonary hypertension in neonates treatment :: Article Creator Vasodilators May Improve Outcomes In Persistent Pulmonary Hypertension In Newborns Various pulmonary vasodilators may improve outcomes in persistent pulmonary hypertension (PPH) in newborns, according to study results submitted to the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2024, held virtually from September 27 to 30, 2024. Inhaled nitric oxide is considered the primary treatment for PPH in newborns, which is associated with a significant increase in neonatal mortality and morbidity. Investigators compared the efficacy of various vasodilators as adjunctive therapy or as second-line therapy for management of PPH in newborns. The investigators conducted a systematic review and network meta-analysis pooling results of 12 randomized controlled trials (RCTs; N=2911 patients) to analyze multiple treatment options including endothelin-1 receptor antagonists, ph